Cargando…

Regulation of one-carbon metabolism may open new avenues to slow down the initiation and progression of Huntington’s disease

Detalles Bibliográficos
Autores principales:	Xie, Jiahua, Kittur, Farooqahmed S., Hung, Chiu-Yueh, Ding, Tomas T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360093/ https://www.ncbi.nlm.nih.gov/pubmed/37282468 http://dx.doi.org/10.4103/1673-5374.371363

Ejemplares similares

Rethinking the necessity of low glucose intervention for cerebral ischemia/reperfusion injury
por: Xie, Jiahua, et al.
Publicado: (2021)

Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
por: Kittur, Farooqahmed S., et al.
Publicado: (2023)

Plant-Produced Asialo-Erythropoietin Restores Pancreatic Beta-Cell Function by Suppressing Mammalian Sterile-20-like Kinase (MST1) and Caspase-3 Activation
por: Arthur, Elena, et al.
Publicado: (2017)

Recombinant asialoerythropoetin protects HL-1 cardiomyocytes from injury via suppression of Mst1 activation
por: Kittur, Farooqahmed S., et al.
Publicado: (2019)

Quantitative Proteomics Reveals the Beneficial Effects of Low Glucose on Neuronal Cell Survival in an in vitro Ischemic Penumbral Model
por: Li, Hua, et al.
Publicado: (2020)

Transcriptional Response of Selenopolypeptide Genes and Selenocysteine Biosynthesis Machinery Genes in Escherichia coli during Selenite Reduction
por: Tetteh, Antonia Y., et al.
Publicado: (2014)

An Effective Way of Producing Fully Assembled Antibody in Transgenic Tobacco Plants by Linking Heavy and Light Chains via a Self-Cleaving 2A Peptide
por: Lin, Yuan, et al.
Publicado: (2018)

Cytoprotective Effect of Recombinant Human Erythropoietin Produced in Transgenic Tobacco Plants
por: Kittur, Farooqahmed S., et al.
Publicado: (2013)

Gibberellin deficiency is responsible for shy-flowering nature of Epipremnum aureum
por: Hung, Chiu-Yueh, et al.
Publicado: (2016)

A plant-based mutant huntingtin model-driven discovery of impaired expression of GTPCH and DHFR
por: Hung, Chiu-Yueh, et al.
Publicado: (2022)

New Avenues for the Treatment of Huntington’s Disease
por: Kim, Amy, et al.
Publicado: (2021)

Transformation of Long-Lived Albino Epipremnum aureum ‘Golden Pothos’ and Restoring Chloroplast Development
por: Hung, Chiu-Yueh, et al.
Publicado: (2021)

Hopping from One Cell to Another: Huntington's Disease Propagates
por: Park, Sang Myun
Publicado: (2017)

Accumulation of high OPDA level correlates with reduced ROS and elevated GSH benefiting white cell survival in variegated leaves
por: Sun, Ying-Hsuan, et al.
Publicado: (2017)

Untapped policy avenues to protect coral reef ecosystems
por: Carlson, Rachel R., et al.
Publicado: (2022)

Antiglycative activity of sulforaphane: a new avenue to counteract neurodegeneration?
por: Angeloni, Cristina, et al.
Publicado: (2015)

Targeting calcium signaling in Alzheimer’s disease: challenges and promising therapeutic avenues
por: Song, LinLin, et al.
Publicado: (2023)

New Avenues in Audio Intelligence: Towards Holistic Real-life Audio Understanding
por: Schuller, Björn, et al.
Publicado: (2021)

A Rapid Alkalinization Factor-like Peptide EaF82 Impairs Tapetum Degeneration during Pollen Development through Induced ATP Deficiency
por: Hung, Chiu-Yueh, et al.
Publicado: (2023)

MicroRNA-124 slows down the progression of Huntington’s disease by promoting neurogenesis in the striatum
por: Liu, Tian, et al.
Publicado: (2015)

Oxidative stress in N88S seipinopathy: novel insights into the mechanisms of neurodegeneration and therapeutic avenues
por: Costa, Vítor, et al.
Publicado: (2022)

Why and How Political Science Can Contribute to Public Health? Proposals for Collaborative Research Avenues
por: Gagnon, France, et al.
Publicado: (2017)

Two viruses, one prescription: slow down
por: Tolley, Rodney, et al.
Publicado: (2022)

Critical slowing down may account for the robustness of development
por: Zhang, Weiting, et al.
Publicado: (2022)

Factors contributing to clinical picture and progression of Huntington's disease
por: Zielonka, Daniel
Publicado: (2018)

Striving for a Realistic and Unapologetic View of Huntington’s Disease
por: Serbin, Kenneth P.
Publicado: (2022)

Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma
por: Ito, Yasuhiro, et al.
Publicado: (2023)

Putting the Brakes on Huntington Disease in a Mouse Experimental Model
por: Kim, Jane C., et al.
Publicado: (2015)

Histone methylation in Huntington’s disease: are bivalent promoters the critical targets?
por: Zsindely, Nóra, et al.
Publicado: (2018)

SCIRT lncRNA slows the formation of tumour initiating cells in breast cancer
por: de Giorgio, Alex, et al.
Publicado: (2021)

Closing the portal to SARS-CoV-2 cellular entry: May open newer avenues…
por: Sharma, Ridhima, et al.
Publicado: (2021)

Slowing Replication in Preparation for Reduction
por: Lawrence, Katherine S., et al.
Publicado: (2012)

Society and the slow burn of inequality
por: Marmot, Michael
Publicado: (2020)

Renin-angiotensin system in the central nervous system: focus on Huntington’s disease
por: de Miranda, Aline Silva, et al.
Publicado: (2023)

COVID-19 subgroups may slow down biological age acceleration
por: Guo, Yu, et al.
Publicado: (2023)

Age-related slowing down in the motor initiation in elderly adults
por: Frolov, Nikita S., et al.
Publicado: (2020)

Open avenues for carotenoid biofortification of plant tissues
por: Morelli, Luca, et al.
Publicado: (2022)

Review of Institute of Medicine and National Research Council Recommendations for One Health Initiative
por: Rubin, Carol, et al.
Publicado: (2013)

Glyco-sphingo biology: a novel perspective for potential new treatments in Huntington's disease
por: Di Pardo, Alba, et al.
Publicado: (2017)

Can leukocyte telomere shortening be a possible biomarker to track Huntington’s disease progression?
por: Mantuano, Elide, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_vdrrmmm1ss9e9fqofr4ihvoiig